Pre-Meal MCT Supplement Timing for Postprandial Glucose Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for diabetes and pre-diabetes, particularly targeting postprandial glucose (PPG), often lead to increased insulin resistance and hypoglycemia, and there is a need for safe, convenient options that effectively reduce PPG without significant insulin level changes.
Innovation Solution
Administering medium chain triglycerides (MCTs) orally about 30 minutes before a meal, followed by the meal within an hour, to significantly decrease PPG without affecting insulin levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional treatments targeting postprandial glucose are administered, then PPG levels are reduced, but insulin resistance increases and hypoglycemia occurs
Solution Approach 1:
MCTs serve as an intermediary substance that indirectly reduces postprandial glucose through alternative metabolic pathways. Instead of directly targeting glucose metabolism (which causes insulin resistance), MCTs are metabolized into ketone bodies that provide alternative fuel sources, thereby reducing the demand for insulin-mediated glucose uptake and avoiding the harmful side effects of traditional glucose-lowering treatments
Solution Approach 2:
The invention changes the metabolic parameter from insulin-dependent glucose utilization to ketone-based energy metabolism. By administering MCTs, the body shifts from using glucose as the primary fuel source to using ketone bodies, fundamentally altering the metabolic pathway and achieving glucose control without insulin resistance
2Measurement precision
If MCTs are administered concurrently with a meal, then some PPG reduction is achieved, but the timing optimization is not realized
Solution Approach 1:
MCTs are administered 30 minutes before the meal to allow preliminary metabolic preparation. This timing enables the MCTs to be metabolized into ketone bodies before glucose enters the system, creating a metabolic environment that is primed to handle the incoming glucose load more effectively, thereby maximizing PPG reduction
3Measurement precision
If multiple drug classes are used to target PPG, then glycemic control is improved, but treatment complexity and side effects increase
Solution Approach 1:
The invention extracts the glucose-lowering effect from the complex multi-drug regimen and achieves it through a single alternative mechanism. By utilizing MCT metabolism and ketone production, the patent isolates an independent pathway that reduces postprandial glucose without requiring combination therapy with multiple drug classes
Solution Approach 2:
MCTs provide multiple beneficial effects simultaneously: they serve as an energy source, generate ketone bodies for alternative fuel, reduce postprandial glucose, and avoid insulin resistance. This multi-functionality replaces the need for multiple specialized drugs, simplifying the treatment regimen while maintaining or improving efficacy
Data Source
AI summary
A method reduces postprandial glucose from a meal. The method includes orally administering to an individual a composition containing medium chain triglycerides (MCT) and then subsequently orally administering the meal to the individual after the oral administration of the composition containing the MCTs and within about one hour of the oral administration of the composition containing the MCTs. For example, the meal can be administered about thirty minutes after the administration of the composition containing the MCTs. The postprandial glucose is reduced relative to postprandial glucose from (i) postprandial glucose from administration of an identically formulated composition containing MCTs at approximately the same time as the administration of the meal and (ii) postprandial glucose from administration of the meal without any MCTs within about one hour before or within about one hour afterward. The composition containing the MCTs can be a liquid oral nutritional supplement (ONS) providing incomplete nutrition.